Su1631 - Proximal Gastric Emptying Analysis in Patients with Suspected Upper GI Motility Disorder: Added Value to Routine Gastric Emptying Scintigraphy

2018 ◽  
Vol 154 (6) ◽  
pp. S-555
Author(s):  
Marvin I. Friedman ◽  
Jesus R. Diaz ◽  
Karen Vaz ◽  
Anna Leykekhman ◽  
Kenneth Dominguez ◽  
...  
2015 ◽  
Vol 81 (7) ◽  
pp. 738-746 ◽  
Author(s):  
Sheri A. Mancini ◽  
Jillian L. Angelo ◽  
Zachary Peckler ◽  
Frances H. Philp ◽  
Katie F. Farah

Gastroparesis is a chronic gastric motility disorder in which the pathophysiology mimics a post-vagotomy state. Pyloroplasty is beginning to emerge as a successful drainage procedure for refractory gastroparesis. Here we report our experience using pyloroplasty in the surgical management of diabetic and nondiabetic gastroparesis. A retrospective study was performed of 46 patients undergoing pyloroplasty for refractory gastroparesis from January 2010 through December 2013. Gastric emptying scintigraphy and the Gastroparesis Cardinal Symptom Index were assessed pre-and postoperatively. Laparoscopic pyloroplasty was performed in 42 patients, open pyloroplasty in three, and one patient was converted from laparoscopic to open pyloroplasty. Studies were repeated during the six to 12 month postoperative interval. The postoperative gastric emptying scintigraphy improved in 90 per cent of patients and normalized in 60 per cent. Postoperative T½ was significantly reduced ( P = 0.001) as was four-hour retention ( P < 0.001). The Gastroparesis Cardinal Symptom Index showed statistically significant reduction in symptom severity for all nine categories ( P < 0.0005) as well as total symptom score ( P < 0.005). No patients developed dumping syndrome. Pyloroplasty is a highly effective therapy for refractory gastroparesis, offering significant reduction in symptom severity, improvement in quality of life, and acceleration of gastric emptying.


2021 ◽  
Vol 75 (2) ◽  
pp. 159-164
Author(s):  
Martina Horváthová ◽  
Zuzana Bárdyová ◽  
Darina Budošová ◽  
Rastislav Husťak

Introduction: Gastric emptying scintigraphy (GES) is a safe, noninvasive method for assessing the ability of the stomach to empty which has been used clinically for many years. It is considered as a “gold standard” to assess gastric emptying of both solids and liquids allowing assessment of early, mid and late emptying, each of which may be altered by pathology. The aim of the study was to analyse standard diagnostic approach and evaluate patients` radiation exposure, who underwent GES in Slovakia. Methods: A retrospective cohort study included 55 patients from 2 departments of nuclear medicine (department A, B). Patients’ radiation exposure was determined by dosimetry program IDAC-Dose2.1. The radiopharmaceutical 99mTc-DTPA, always with the same activity, was applied orally to patients at Department B. The applied activity of the radiopharmaceutical at GES was 185 MBq. The radiopharmaceutical 99mTc MAA, with various activity, was applied orally to patients at Department A. Results: According to ICRP60, the eff ective dose (ED) of every patient undergoing GES was 0.77 mSv and, according to ICRP103, the dose was 0.836 mSv at Department B. Patients at Department A were exposed to ionizing radiation with 5-times lower intensity, compared with patients at Department B. It was caused by radiopharmaceutical activity correction. The ED medians according to ICRP60, and according to ICRP103 were 0.167 mSv (range 0.105–0.208 mSv) and 0.181 mSv (range 0.113–0.226 mSv) at Department A, respectively. Discussion: Adequate correction of applied radiopharmaceutical activity is an essential part of GES guidelines and in accordance with ALARA principles. For the accuracy of GES examination, it is necessary to follow a standard 4-hour protocol and an approach which ensures full-featured utilization of the examination while decreasing patient`s radiation exposure. Conclusion: The results of our study show relatively low ED associated with GES, but also confi rm that the GES methodology significantly affects the patient`s radiation exposure


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sharon Wolfson ◽  
Zoe Wilhelm ◽  
Antone R. Opekun ◽  
Robert Orth ◽  
Robert J. Shulman ◽  
...  

Gastroparesis ◽  
2021 ◽  
pp. 125-142
Author(s):  
Alan H. Maurer ◽  
Marvin I. Friedman ◽  
Jesus Diaz ◽  
Henry P. Parkman

Sign in / Sign up

Export Citation Format

Share Document